Patents by Inventor Alfred Garfall

Alfred Garfall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers predictive of cytokine release syndrome
    Patent number: 11747346
    Abstract: The present disclosure relates to the identification and use of biomarkers (e.g., analytes, analyte profiles, or markers (e.g., gene expression and/or protein expression profiles)) with clinical relevance to cytokine release syndrome (CRS).
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: September 5, 2023
    Assignees: Novartis AG, The Trustees of the University of Pennsylvania
    Inventors: Alfred Garfall, Alex Ganetsky, Saar Gill, Simon Lacey, Jan J. Melenhorst, David Teachey, Eric Lancaster, Adam David Cohen, Pamela Shaw
  • BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR, AND USES THEREOF
    Publication number: 20200371091
    Abstract: The invention provides compositions and methods for treating diseases associated with expression of BCMA. The invention also relates to a method of administering a BCMA-targeting chimeric antigen receptor (CAR) therapy and an additional therapeutic agent.
    Type: Application
    Filed: November 30, 2018
    Publication date: November 26, 2020
    Inventors: Iulian Pruteanu-Malinici, Keith Mansfield, Boris Engels, Jan J. Melenhorst, Adam David Cohen, Edward A. Stadtmauer, Alfred Garfall, Michael C. Milone, Joseph A. Fraietta
  • BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR, CD19-TARGETING CHIMERIC ANTIGEN RECEPTOR, AND COMBINATION THERAPIES
    Publication number: 20200360431
    Abstract: The invention provides compositions and methods for treating diseases associated with expression of BCMA. The invention also relates to a method of administering a BCMA-targeting chimeric antigen receptor (CAR) therapy and an additional therapeutic agent.
    Type: Application
    Filed: November 15, 2018
    Publication date: November 19, 2020
    Inventors: Alfred Garfall, Adam David Cohen, Michael C. Milone, Gabriela Plesa, Edward A. Stadtmauer, Carl H. June
  • BIOMARKERS PREDICTIVE OF CYTOKINE RELEASE SYNDROME
    Publication number: 20180252727
    Abstract: The present disclosure relates to the identification and use of biomarkers (e.g., analytes, analyte profiles, or markers (e.g., gene expression and/or protein expression profiles)) with clinical relevance to cytokine release syndrome (CRS).
    Type: Application
    Filed: September 2, 2016
    Publication date: September 6, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Alfred Garfall, Alex Ganetsky, Saar Gill, Simon Lacey, Jan J. Melenhorst, David Teachey